lobbying_activities: 1001432

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1001432	65da2f63-b859-4ce3-b900-e77bcb08476a	Q3	TARPLIN, DOWNS & YOUNG, LLC	304736	ASTRAZENECA	2010	third_quarter	HCR	**see addendum page S. 301/H.R. 3138 Physician Payments Sunshine Act of 2009, disclosure Biosimilars S. 726/H.R. 1427 Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 The Pathway for Biosimilars Act PL 111-148 The Patient Protection and Affordable Care Act, implementation, health care reform, drug importation, follow-on biologics, 340b, comparative effectiveness, gift disclosure, Medicaid and Medicare reimbursement	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2010-10-19T10:58:05.333000-04:00